Log In
BCIQ
Print this Print this
 

ABY-021

  Manage Alerts
Collapse Summary General Information
Company amp biosimilars AG
DescriptionHumanized mAb biosimilar
Molecular Target
Mechanism of ActionAntibody; Biosimilar
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat unspecified immunological indications
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/10/2015

Undisclosed

0

0

Get a free BioCentury trial today